← Open Payments lookup

APHIE AMAMS: Open Payments

NPI 1497398861 · ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,031 in 55 payments from 10 companies in 2025. Trend: 2023 $468 · 2024 $607 · 2025 $1,031

Food & beverage: $1,031
CompanyPaymentsAmount
ABBVIE INC.20$365
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$236
Alkermes, Inc.5$96
Vanda Pharmaceuticals Inc.6$92
Janssen Pharmaceuticals, Inc5$79
Otsuka America Pharmaceutical, Inc.2$63
Janssen Scientific Affairs, LLC1$31
Neurocrine BioSciences, Inc.2$28
Supernus Pharmaceuticals, Inc.1$26
Lundbeck LLC1$15

Products named: VRAYLAR, CAPLYTA, ARISTADA, INVEGA SUSTENNA, REXULTI, FANAPT, HETLIOZ, INGREZZA.

Industry payments across NJ — which companies pay providers there.